D-Kimia is a cutting-edge brand that specializes in developing innovative diagnostic solutions for a range of viral targets, including Hepatitis C. Their mission is to support global efforts in preventing and stopping life-threatening diseases, particularly in low-resource settings. Led by a team of experts, D-Kimia is committed to creating sensitive, affordable, and reliable diagnostic tests that require minimal infrastructure.

The team includes Karim Hussein, the Chief Executive Officer and Co-founder, who brings extensive experience in marketing and business development. Dr. Hassan Azzazy, the President and Chief Science Officer and Co-founder, is a recognized expert in clinical laboratory medicine, biotechnology, and nanodiagnostics.

D-Kimia's product range includes novel and affordable diagnostic solutions for detecting a broad range of diseases, with a primary focus on Hepatitis C identification. They have also developed innovative assays utilizing gold nanoparticles, allowing for rapid and simple detection of diseases, even in point-of-care testing scenarios. For those seeking reliable and accessible diagnostics, D-Kimia is at the forefront of delivering solutions that can make a significant impact in the field of healthcare